flow trial semaglutide kidney outcomes nejm 2024 hazard ratio 0.76 clinical (funded by Novo Nordisk) SGLT2 Inhibitors in the Management

Rapid weight loss tends to reduce not only fat mass but also lean body mass, which includes muscle

They are now racing to develop their own pills for obesity and diabetes

It is a powerful tool that works best when paired with intentional nutrition and lifestyle habits

Taken together, the human imaging and animal data are most consistent with plaque stabilization rather than gross atheroma regression, though the causal mechanism remains an inference rather than a directly proven pathway

Healing from runners knee depends on how serious the injury is and how well you are able to support your own rehabilitation

2025 Oct;155(10):3152-3167